Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Vedanta Biosciences
company
About
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.
- 51 - 100
Details
- Last Funding Type
- Private Equity（PE）
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Business Development,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$111.99M
Vedanta Biosciences has raised a total of
$111.99M
in funding over 2 rounds. Their latest funding was raised on
Sep 23, 2019 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 23, 2019 | Series C | $16.60M | 2 | — | — | Detail |
| Dec 24, 2018 | Series C | $45.39M | 1 | — | — | Detail |
| Jun 6, 2016 | Private Equity（PE） | $50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Vedanta Biosciences is funded by 4 investors.
Shinhan Private Equity
and FC Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Shinhan Private Equity
|
— | Series C |
|
|
— | Series C |
|
|
— | Series C |
Invesco
|
— | Private Equity（PE） |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
